RxRevu, a provider of medication cost transparency solutions to identify cost-saving opportunities on prescription drugs, closed its Series B funding round of $7 million. JAZZ
![RxRevu Raises $7 Million For Medication Price Transparency Platform](https://mercomcapital.com/wp-content/uploads/2021/01/RxRevu-Raises-7-Million-For-Medication-Price-Transparency-Platform.png)
RxRevu, a provider of medication cost transparency solutions to identify cost-saving opportunities on prescription drugs, closed its Series B funding round of $7 million. JAZZ